Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Synergistic interaction of a geldanamycin analog (17AAG) and radiation in human prostate tumor spheroids
    Meeting Abstract

    Enmon, R. M.; Yang, W.; Solit, D. B.; Ballangrud, A. M.; Rosen, N.; Scher, H. I.; Sgouros, G.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Cellular and molecular characterization of circulating breast tumor cells after Leukapheresis in breast carcinoma (BC) patients by RT-PCR, Immunohistochemistry (IHC), laser scanning confocal microscopy (LSCM), laser scanning cytometer (LSC), and fluorescent in situ hybridization (FISH)
    Meeting Abstract

    Bhattacharya, S.; Juan, G.; Hudis, C.; Scher, H. I.; Rosen, N.; Hutchinson, B.; Salazar, P. A.; Desai, S.; Ladanyi, M.; Cardon-Cardo, C.; more...
    Analytical Cellular Pathology (2002)

    Fulltext@MSK | Save
  • The Akt protein kinase is a direct target of ansamycin antibiotics
    Meeting Abstract

    Basso, A. D.; Solit, D.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Inhibition of the PI3 kinase/Akt pathway mediates the antitumor effects of ZD1839 (Iressa) in HER2-overexpressing tumors
    Meeting Abstract

    Basso, A.; Averbuch, S. D.; Rosen, N.; Moasser, M. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Estrogen and progesterone receptor status, p53 and Her-2/neu protein expression in metachronous bilateral breast carcinoma (MBBC)
    Meeting Abstract

    Vrcel, V.; Brogi, E.; Cranor, M. L.; Son, T.; Hudis, C.; Norton, L.; Tan, L. K.
    Modern Pathology (2002)

    Fulltext@MSK | Save
  • Occult or micrometastasis (O/MM) in axillary lymph nodes (ALN) of node negative breast cancer (NNBC): How does one measure it?
    Meeting Abstract

    Giri, D.; Brogi, E.; Cranor, M. L.; Bevilacqua, J.; Hudis, C.; Norton, L.; Borgen, P.; Tan, L. K.
    Modern Pathology (2002)

    Fulltext@MSK | Save
  • Estrogen and progesterone receptor status, p53 and Her-2/neu protein expression in metachronous bilateral breast carcinoma (MBBC)
    Meeting Abstract

    Vrcel, V.; Brogi, E.; Cranor, M. L.; Son, T.; Hudis, C.; Norton, L.; Tan, L. K.
    Laboratory Investigation (2002)

    Fulltext@MSK | Save
  • Occult or micrometastasis (O/MM) in axillary lymph nodes (ALN) of node negative breast cancer (NNBC): How does one measure it?
    Meeting Abstract

    Giri, D.; Brogi, E.; Cranor, M. L.; Bevilacqua, J.; Hudis, C.; Norton, L.; Borgen, P.; Tan, L. K.
    Laboratory Investigation (2002)

    Fulltext@MSK | Save
  • Clinical heterogeneity in breast cancer
    Meeting Abstract

    Hudis, C.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Serum creatinine (Cr) values in patients with metastatic breast cancer (MBC) treated with pamidronate (PAM) administered as an intravenous 1 hour infusion (1 h)
    Meeting Abstract

    Van Poznak, C.; Ben-Porat, L.; Panageas, K.; Leone, D.; Seidman, A.; Hudis, C.
    Bone (2002)

    Fulltext@MSK | Save